Syndax Announces Participation at Two Upcoming Investor Conferences

Rhea-AI Summary

Syndax Pharmaceuticals, a clinical-stage biopharmaceutical company, has announced participation in two investor conferences. Management will engage in a virtual fireside chat at Cowen's 3rd Annual Oncology Innovation Summit on June 2, 2022, at 12:30 p.m. ET. Additionally, they will partake in a fireside chat at Goldman Sachs' 43rd Annual Global Healthcare Conference on June 14, 2022, at 6:20 p.m. ET in Rancho Palos Verdes, CA. Live webcasts of both events will be accessible on their website, along with a limited-time replay.

WALTHAM, Mass., May 26, 2022 /PRNewswire/ -- Syndax Pharmaceuticals, Inc. ("Syndax," the "Company" or "we") (Nasdaq: SNDX), a clinical-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that members of its management team will participate in two upcoming investor conferences:

• A virtual fireside chat at Cowen's 3rd Annual Oncology Innovation Summit at 12:30 p.m. ET on Thursday, June 2, 2022.
• A fireside chat at the Goldman Sachs 43rd Annual Global Healthcare Conference at 6:20 p.m. ET/ 3:20 p.m. PT on Tuesday, June 14, 2022 in Rancho Palos Verdes, CA.

A live webcast of the fireside chats can be accessed from the Investor section of the Company's website at www.syndax.com, where a replay of the events will also be available for a limited time.

About Syndax Pharmaceuticals, Inc.

Syndax Pharmaceuticals is a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies. Highlights of the Company's pipeline include revumenib (SNDX-5613), a highly selective inhibitor of the Menin–MLL binding interaction, and axatilimab, a monoclonal antibody that blocks the colony stimulating factor 1 (CSF-1) receptor, both currently in pivotal trials. For more information, please visit www.syndax.com or follow the Company on Twitter and LinkedIn.

Syndax Contacts

Investor Contact
Melissa Forst
Argot Partners
melissa@argotpartners.com 
Tel 212.600.1902

Media Contact
Benjamin Kolinski
benjamin.kolinski@gcihealth.com Tel 862.368.4464

SNDX-G 

View original content:https://www.prnewswire.com/news-releases/syndax-announces-participation-at-two-upcoming-investor-conferences-301555294.html

SOURCE Syndax Pharmaceuticals, Inc.

FAQ

What conferences will Syndax Pharmaceuticals participate in June 2022?

Syndax will participate in Cowen's 3rd Annual Oncology Innovation Summit on June 2, 2022, and Goldman Sachs' 43rd Annual Global Healthcare Conference on June 14, 2022.

When is the Cowen's Oncology Innovation Summit for Syndax?

The Cowen's 3rd Annual Oncology Innovation Summit is on June 2, 2022, at 12:30 p.m. ET.

Where will the Goldman Sachs Global Healthcare Conference take place?

The Goldman Sachs 43rd Annual Global Healthcare Conference will be held in Rancho Palos Verdes, CA.

What is the stock symbol for Syndax Pharmaceuticals?

The stock symbol for Syndax Pharmaceuticals is SNDX.

How can I view the Syndax Pharmaceuticals investor conferences live?

You can view the live webcasts of the investor conferences on the Investor section of Syndax's website.